TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Incidence of detectable anti-insulin antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Median antibody levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Development of TEAR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in symptom networks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Force exerted on the incisors during intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cormack‐Lehane scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient self-sufficiency (Barthel index)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: pressurized footprint coverage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-reported dizziness-related impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: balance performance with and without head movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reported ITN use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reported IPTp uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tibial migration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inducible displacement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Range of motion gained
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum flexion achieved
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of Schistosoma haematobium egg excretion rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cure rates at 4- and 6-weeks post-treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evidence-concordant IV fluid ordering
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative incidence of prediabetes reversal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: IIQ-7 scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PFM performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perception of loneliness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Level of moderate physical exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain on the first postoperative day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Exposure to Treatment-Emergent Adverse Events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Culturally appropriate cutoff scores for Reliable Digit Span
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Culturally appropriate cutoff scores for Phonetic Fluency Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Culturally appropriate cutoff scores for Semantic Fluency Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: nonhematologic CTC grade 3 and 4 toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Increase in whole-body lean mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in percent body fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Decrease in serum alkaline phosphatase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distance metastasis-free survival (DMFS)
Endpoint domain: Mortality/survival
Primary endpoint: Tear production improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peri-implantitis incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: no need for any urinary protection at 6 months after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Proportion of treated AK areas responding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Pain duration
Endpoint domain: Adverse events/effects
Primary endpoint: V̇o2peak
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Maximal isometric knee extensor muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: improvement in practices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in decision-making
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Competence in arthrocentesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of off-medication motor symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of sleep disturbances
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in verbal fluency
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: mean health utility score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: perceived enjoyment and benefits of socializing while exercising together
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: time expenditure perceived to be acceptable
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: perceptions that ambience and accessibility of exercise facilities in the neighborhood were important
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: improvement in prenatal bonding
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: improvement in prenatal relationship functioning (RF)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Prevalence of folic acid deficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Prevalence of excessive folic acid intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Increase in DFE intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Continuation of exclusive breastfeeding
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Cognitive stimulation (StimQ common total)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: READ Quantity
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: READ Quality
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: smear layer and debris removal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain experienced during venous port access
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of EMS calls for stroke suspicion
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Recognition of at least 2 stroke warning signs
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Cough effectiveness measured with the peak cough expiratory flow (PCEF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Specific and generic health‐related quality of life measures (PDQ‐39, Euro‐QoL‐VAS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Diary-recorded seizure counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GPFA discharges per hour of sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative mortality prediction
Endpoint domain: Mortality/survival
Primary endpoint: decline in composite cognitive score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: decline in MMSE score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Constant‐Murley Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ATEC score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: composition of intestinal flora
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative SNOT‐22 scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: rate of diarrhea
Endpoint domain: Adverse events/effects
Primary endpoint: maximum ankle dorsiflexion in the single‐support phase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peak ankle plantar flexor moment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: power ankle generation during preswing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Invagination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Misdirection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Flow-mediated dilatation (%FMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Endothelin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: office BP reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 24-h BP change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Occurrence of caries
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Salivary concentration of hβD‐3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of symptoms of chronic lung disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: QFT conversion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: 30-day composite cardiovascular mortality or HF rehospitalization
Endpoint domain: Mortality/survival
Primary endpoint: Self-efficacy in adhering to home yoga practice
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Observed competency in performing yoga postures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: post-task state anxiety
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Daily SMBG frequency below clinical threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: myocardial injury (lower troponin T release)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Point retinal sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PSE for promoting healthy dietary behaviors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of a recovery-promoting relationship
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Unplanned reattendances within 7 days
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: RMDQ scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total healthcare costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Length z scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: First and recurrent HF hospitalizations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Hyperkalemia events
Endpoint domain: Adverse events/effects
Primary endpoint: IgG GMCs of shared serotypes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Serotype 3 OPA GMTs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Weighted Cohen's kappa of number of lesioned segments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Agreement concerning the Durie-Salmon PLUS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Willingness to donate organs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Certainty that the patient was truly dead
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: fatigability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: ACR50 achievement at week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DAS28-CRP <2.6 achievement at week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: No radiographic progression (modified total Sharp score ≤0)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: conjunctival redness scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LLDAS (Low Lupus Disease Activity State)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival free of aseptic loosening
Endpoint domain: Mortality/survival
Primary endpoint: Survival free of any revision
Endpoint domain: Mortality/survival
Primary endpoint: mean score of estimated total VSS
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: all-cause death rate at 60 months
Endpoint domain: Mortality/survival
Primary endpoint: major adverse cardiovascular event rate at 60 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: buccal tissue collapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mid-facial gingival margin position
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: radiographic new bone formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: steroid-induced IOP rise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Tooth size measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preference for dPET
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Detection of FDG-avid lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Good ART adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Suppressed viral loads
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wear to opposing teeth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical health outcomes
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Completion of Lung Cancer Screening (LCS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delta-TSS-34
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Debriefing duration
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: decrement of the global QoR‐40 score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Interval time for P-ECG vs C-ECG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: depression-dejection improvement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: vascular decongestion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: CTRS-R/L improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BRIEF-Teacher form improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of positive culture results immediately after skin preparation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Aberdeen Varicose Veins Questionnaire Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: knowledge gains
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Understanding of ventricular septal defect anatomy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Understanding of the surgical procedure and potential complications
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Sensitivity, specificity, and positive predictive value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Prevalence of therapeutic inertia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: treatment completer status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: discharge status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global MMAS‐8 scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Donation intentions
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Initial success rate of biliary cannulation (ISRBC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Improvement in self-perception of confidence in providing acute stroke care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in management due to re-interpretation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in preferred type of EOL care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time until union
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to return to pre-fracture activity level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global measure of cognition, attention, and mental speed processing
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Predictive performance for pathological grading of HCC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intrusiveness of monitoring modalities
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Expectation of cure from pancreatic cancer
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Probability of having a COVID-19 test taken
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 7-day NIHSS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Favorable functional outcomes at 90 days
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Levels of Rifampicin-resistant E. coli in irrigation water
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Prediction of LVSI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean instrumentation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risk of suicide
Endpoint domain: Adverse events/effects
Primary endpoint: success rate of teeth treated with GP paste
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Water content in the left cheek
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of AERO intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability to participants and physiotherapists
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Successful introduction of milk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean percent change in inflammatory lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean percent change in noninflammatory lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prediction of microvascular invasion (MVI) in HCC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MDS-UPDRS score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of post-herpetic neuralgia
Endpoint domain: Adverse events/effects
Primary endpoint: Enrichment of Veillonella
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CNLBP disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Incidence of neonatal metabolic acidosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of operative vaginal delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: perceived ability to handle distressing communication
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Lapse risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percent days heavy drinking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean grams ethanol consumed per week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: contact angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes